This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1t3c

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1t3c.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:1t3c.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1t3c| PDB=1t3c | SCENE= }}
{{STRUCTURE_1t3c| PDB=1t3c | SCENE= }}
-
'''Clostridium botulinum type E catalytic domain E212Q mutant'''
+
===Clostridium botulinum type E catalytic domain E212Q mutant===
-
==Overview==
+
<!--
-
The seven serotypes of botulinum neurotoxins (A-G) produced by Clostridium botulinum share significant sequence homology and structural similarity. The functions of their individual domains and the modes of action are also similar. However, the substrate specificity and the peptide bond cleavage selectivity of their catalytic domains are different. The reason for this unique specificity of botulinum neurotoxins is still baffling. If an inhibitor leading to a therapeutic drug common to all serotypes is to be developed, it is essential to understand the differences in their three-dimensional structures that empower them with this unique characteristic. Accordingly, high-resolution structures of all serotypes are required, and toward achieving this goal the crystal structure of the catalytic domain of C. botulinum neurotoxin type E has been determined to 2.1 A resolution. The crystal structure of the inactive mutant Glu212--&gt;Gln of this protein has also been determined. While the overall conformation is unaltered in the active site, the position of the nucleophilic water changes in the mutant, thereby causing it to lose its ability to activate the catalytic reaction. The structure explains the importance of the nucleophilic water and the charge on Glu212. The structural differences responsible for the loss of activity of the mutant provide a common model for the catalytic pathway of Clostridium neurotoxins since Glu212 is conserved and has a similar role in all serotypes. This or a more nonconservative mutant (e.g., Glu212--&gt;Ala) could provide a novel, genetically modified protein vaccine for botulinum.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15157097}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15157097 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15157097}}
==About this Structure==
==About this Structure==
Line 32: Line 36:
[[Category: E212q mutant]]
[[Category: E212q mutant]]
[[Category: Light chain]]
[[Category: Light chain]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 09:28:04 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 15:11:14 2008''

Revision as of 12:11, 28 July 2008

Image:1t3c.png

Template:STRUCTURE 1t3c

Clostridium botulinum type E catalytic domain E212Q mutant

Template:ABSTRACT PUBMED 15157097

About this Structure

1T3C is a Single protein structure of sequence from Clostridium botulinum. Full crystallographic information is available from OCA.

Reference

Structural analysis of botulinum neurotoxin type E catalytic domain and its mutant Glu212-->Gln reveals the pivotal role of the Glu212 carboxylate in the catalytic pathway., Agarwal R, Eswaramoorthy S, Kumaran D, Binz T, Swaminathan S, Biochemistry. 2004 Jun 1;43(21):6637-44. PMID:15157097

Page seeded by OCA on Mon Jul 28 15:11:14 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1t3c"
Personal tools